Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822893) titled 'Evaluation of the Effect of Botulinum Toxin on Resting Tremor of the Refractory Upper Limb in Parkinsonians, Cross-over Study, Double Blind and Placebo-controlled' on Sept. 10.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: University Hospital, Toulouse

Condition: PARKINSON DISEASE (Disorder)

Intervention: Drug: Injection of Dysport then placebo

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: October 2026

Target Sample Size: 39 ...